Compounds > betulinic acid

betulinic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

betulinic acid has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Castro, MM; Duarte, IF; Duarte, MF; Guerra, ÂR; Oliveira, H; Paulino, AF1
Chatterji, U; Das, S; Ghosh, S; Halder, A; Helal Uddin, ABM; Jethwa, M; Mukherjee, A; Mukherjee, P; Roy, P1
Bache, M; Eiselt, Y; Funtan, A; Güttler, A; Keßler, J; Paschke, R; Petrenko, M; Thiel, A; Thondorf, I; Vordermark, D1

Other Studies

3 other study(ies) available for betulinic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Triple Negative Breast Cancer and Breast Epithelial Cells Differentially Reprogram Glucose and Lipid Metabolism upon Treatment with Triterpenic Acids.
    Biomolecules, 2020, 08-08, Volume: 10, Issue:8

    Topics: Betulinic Acid; Breast; Cell Cycle; Cell Line, Tumor; Cell Survival; Citric Acid Cycle; Epithelial Cells; Female; Glucose; Glycolysis; Hexosamines; Humans; Lipid Metabolism; Magnetic Resonance Spectroscopy; Metabolome; Metabolomics; Pentacyclic Triterpenes; Triple Negative Breast Neoplasms; Triterpenes; Ursolic Acid

2020
Lactoferrin-tethered betulinic acid nanoparticles promote rapid delivery and cell death in triple negative breast and laryngeal cancer cells.
    Artificial cells, nanomedicine, and biotechnology, 2020, Nov-17, Volume: 48, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Betulinic Acid; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Humans; Lactoferrin; Laryngeal Neoplasms; Nanoparticles; Particle Size; Pentacyclic Triterpenes; Triple Negative Breast Neoplasms

2020
Betulin Sulfonamides as Carbonic Anhydrase Inhibitors and Anticancer Agents in Breast Cancer Cells.
    International journal of molecular sciences, 2021, Aug-16, Volume: 22, Issue:16

    Topics: Antigens, Neoplasm; Antineoplastic Agents; Betulinic Acid; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Humans; MCF-7 Cells; Models, Molecular; Molecular Docking Simulation; Pentacyclic Triterpenes; Radiation Tolerance; Sulfonamides; Triple Negative Breast Neoplasms

2021